カテゴリ： MarketLine, イギリス, 企業調査

The Royal Bank of Scotland Group Plc：企業の戦略・SWOT・財務情報

◆英語タイトル：The Royal Bank of Scotland Group Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C3957
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：60
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

The Royal Bank of Scotland Group Plc – Strategy, SWOT and Corporate Finance Report
Summary

The Royal Bank of Scotland Group Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

The Royal Bank of Scotland Group plc (RBS) is a bank holding company operating through two key subsidiaries and offers personal, premier, business, and international banking and related financial services. Personal banking comprises accounts, cards, loans and mortgages, insurance, and investments. Premier banking contains accounts, mortgages, will writing and execution, and estate administration. Business banking includes cards and payments, business loans and finances, business supports, and international finance. International banking encompasses personal, corporate, and offshore banking. It serves to personal, commercial, large corporate and institutional clients through branch offices, ATMs, online portals, and representative offices. The bank operates in Europe, Asia Pacific, the Middle East, Africa, and the Americas. RBS is headquartered in Edinburg, the UK.

Scope

- Detailed information on The Royal Bank of Scotland Group Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting The Royal Bank of Scotland Group Plc in the form of a SWOT analysis
- An in-depth view of the business model of The Royal Bank of Scotland Group Plc including a breakdown and examination of key business segments
- Intelligence on The Royal Bank of Scotland Group Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about The Royal Bank of Scotland Group Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of The Royal Bank of Scotland Group Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess The Royal Bank of Scotland Group Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on The Royal Bank of Scotland Group Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
The Royal Bank of Scotland Group Plc: Company Overview 9
The Royal Bank of Scotland Group Plc: Overview and Key Facts 9
The Royal Bank of Scotland Group Plc: Overview 9
The Royal Bank of Scotland Group Plc: Key Facts 9
The Royal Bank of Scotland Group Plc: Key Employees 11
The Royal Bank of Scotland Group Plc: Key Employee Biographies 13
The Royal Bank of Scotland Group Plc: Major Products and Services 20
The Royal Bank of Scotland Group Plc: Company History 22
The Royal Bank of Scotland Group Plc: Management Statement 27
The Royal Bank of Scotland Group Plc: Locations and Subsidiaries 32
The Royal Bank of Scotland Group Plc: Key Competitors 35
The Royal Bank of Scotland Group Plc: Company Analysis 36
The Royal Bank of Scotland Group Plc: Business Description 36
The Royal Bank of Scotland Group Plc: SWOT Analysis 38
The Royal Bank of Scotland Group Plc: SWOT Overview 38
The Royal Bank of Scotland Group Plc: Strengths 38
The Royal Bank of Scotland Group Plc: Weaknesses 39
The Royal Bank of Scotland Group Plc: Opportunities 39
The Royal Bank of Scotland Group Plc: Threats 40
The Royal Bank of Scotland Group Plc: Corporate Financial Deals Activity 41
The Royal Bank of Scotland Group Plc: Financial Deals Overview 41
The Royal Bank of Scotland Group Plc: Targets and Partners 43
The Royal Bank of Scotland Group Plc: Top Deals 2014 – 2018YTD* 44
The Royal Bank of Scotland Group Plc: Advisors 45
The Royal Bank of Scotland Group Plc: Top Legal Advisors 45
The Royal Bank of Scotland Group Plc: Top Financial Advisors 45
The Royal Bank of Scotland Group Plc: Corporate Venturing 47
The Royal Bank of Scotland Group Plc: Capital Raising 48
The Royal Bank of Scotland Group Plc: Divestments 49
The Royal Bank of Scotland Group Plc: Recent Developments 50
The Royal Bank of Scotland Group Plc: News and Events Summary 50
The Royal Bank of Scotland Group Plc: Business Expansion 53
The Royal Bank of Scotland Group Plc: Business Reorganization 53
The Royal Bank of Scotland Group Plc: Contracts 54
The Royal Bank of Scotland Group Plc: Corporate Governance 54
The Royal Bank of Scotland Group Plc: Financial Deals 54
The Royal Bank of Scotland Group Plc: Financial Performance 55
The Royal Bank of Scotland Group Plc: Red Flags/Distress Signals 55
The Royal Bank of Scotland Group Plc: Red Flags/DistressSignals 55
The Royal Bank of Scotland Group Plc: Regulatory and Legal Events 56
The Royal Bank of Scotland Group Plc: Research & Development 56
The Royal Bank of Scotland Group Plc: Strategy and Operations 57
Appendix 58
Contact Us 58
Methodology 58
About MarketLine 59

List of Tables
Table 1: The Royal Bank of Scotland Group Plc: Key Facts
Table 2: The Royal Bank of Scotland Group Plc: Key Employees
Table 3: The Royal Bank of Scotland Group Plc: Locations and Subsidiaries
Table 4: The Royal Bank of Scotland Group Plc: Key Competitors
Table 5: The Royal Bank of Scotland Group Plc: Deal Activity by Deal Type - Volume (TTM*)
Table 6: The Royal Bank of Scotland Group Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: The Royal Bank of Scotland Group Plc: Targets and Partners
Table 8: The Royal Bank of Scotland Group Plc: Top Deals 2014 - 2018YTD*
Table 9: The Royal Bank of Scotland Group Plc: Legal Advisor Ranking by Value (US$m)
Table 10: The Royal Bank of Scotland Group Plc: Financial Advisor Ranking by Value (US$m)
Table 11: The Royal Bank of Scotland Group Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 12: The Royal Bank of Scotland Group Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Table 13: The Royal Bank of Scotland Group Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 14: The Royal Bank of Scotland Group Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Table 15: The Royal Bank of Scotland Group Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 16: The Royal Bank of Scotland Group Plc: Divestments by Geography (2014 - YTD*2018)
Table 17: The Royal Bank of Scotland Group Plc: News and Events Summary
Table 18: The Royal Bank of Scotland Group Plc: Business Expansion
Table 19: The Royal Bank of Scotland Group Plc: Business Reorganization
Table 20: The Royal Bank of Scotland Group Plc: Contracts
Table 21: The Royal Bank of Scotland Group Plc: Corporate Governance
Table 22: The Royal Bank of Scotland Group Plc: Financial Deals
Table 23: The Royal Bank of Scotland Group Plc: Financial Performance
Table 24: The Royal Bank of Scotland Group Plc: Red Flags/Distress Signals
Table 25: The Royal Bank of Scotland Group Plc: Red Flags/DistressSignals
Table 26: The Royal Bank of Scotland Group Plc: Regulatory and Legal Events
Table 27: The Royal Bank of Scotland Group Plc: Research & Development
Table 28: The Royal Bank of Scotland Group Plc: Strategy and Operations

List of Figures
Figure 1: The Royal Bank of Scotland Group Plc: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: The Royal Bank of Scotland Group Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: The Royal Bank of Scotland Group Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 4: The Royal Bank of Scotland Group Plc: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 5: The Royal Bank of Scotland Group Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 6: The Royal Bank of Scotland Group Plc: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 7: The Royal Bank of Scotland Group Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 8: The Royal Bank of Scotland Group Plc: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[The Royal Bank of Scotland Group Plc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Co-Diagnostics Inc-医療機器分野：企業M&A・提携分析
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • Senhwa Biosciences Inc (6492)：製薬・医療：M&Aディール及び事業提携情報
    Summary Senhwa Biosciences Inc (Senhwa) is a clinical stage drug development company that develops next generation DNA damage response drugs for the treatment of cancer. The company’s pipeline products include CX-5461 and CX-4945. Its CX-5461, a G4-stabilizing compound, is a Pol I inhibitor that tri …
  • Heidelberg Pharma AG (WL6)：製薬・医療：M&Aディール及び事業提携情報
    Summary Heidelberg Pharma AG (Heidelberg Pharma) formerly, Wilex AG is a biopharmaceutical company. The company develops therapeutic and diagnostic product candidates for the treatment and specific detection of various cancers. Heidelberg Pharma’s pipeline products are focused on treating multiple m …
  • Alliance Data Systems Corporation：企業の戦略・SWOT・財務分析
    Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Alliance Data Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Kuraray Co., Ltd.：企業の戦略・SWOT・財務情報
    Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kuraray Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ansell Limited (ANN)：医療機器：M&Aディール及び事業提携情報
    Summary Ansell Limited (Ansell) is a provider of protection solutions. It develops, manufactures and markets a broad range of hand and arm protection solutions and hospital clothing. It also offers medical gloves and healthcare and industrial safety solutions. Ansell offers its products to healthcar …
  • Taerim Packaging Co., Ltd：企業の戦略・SWOT・財務情報
    Taerim Packaging Co., Ltd - Strategy, SWOT and Corporate Finance Report Summary Taerim Packaging Co., Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Rockwool International AS：戦略・SWOT・企業財務分析
    Rockwool International AS - Strategy, SWOT and Corporate Finance Report Summary Rockwool International AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Japan Display Inc：企業の戦略・SWOT・財務情報
    Japan Display Inc - Strategy, SWOT and Corporate Finance Report Summary Japan Display Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Fraser & Neave Holdings Bhd：戦略・SWOT・企業財務分析
    Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report Summary Fraser & Neave Holdings Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • General Electric Company：企業の戦略・SWOT・財務情報
    General Electric Company - Strategy, SWOT and Corporate Finance Report Summary General Electric Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sucrerie Couplet SA：企業の戦略・SWOT・財務情報
    Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report Summary Sucrerie Couplet SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Guess, Inc.：企業の戦略・SWOT・財務情報
    Guess, Inc. - Strategy, SWOT and Corporate Finance Report Summary Guess, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • U-Shin Ltd.：企業の戦略的SWOT分析
    U-Shin Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Vistin Pharma AS (VISTIN)-製薬・医療分野：企業M&A・提携分析
    Summary Vistin Pharma AS (Vistin), a subsidiary of Vistin Pharma ASA is a healthcare company that produces and supplies solid dosage forms and active pharmaceutical ingredients. The company’s products include metformin, an API for the treatment of diabetes II; opioids, an analgesics and antitussive; …
  • Charles River Laboratories International Inc (CRL)-製薬・医療分野：企業M&A・提携分析
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • Coherent Inc (COHR)：企業の財務・戦略的SWOT分析
    Coherent Inc (COHR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • First Majestic Silver Corp：企業の戦略・SWOT・財務情報
    First Majestic Silver Corp - Strategy, SWOT and Corporate Finance Report Summary First Majestic Silver Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Bank Zachodni WBK SA：戦略・SWOT・企業財務分析
    Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report Summary Bank Zachodni WBK SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • United Orthopedic Corp (4129)-医療機器分野：企業M&A・提携分析
    Summary United Orthopedic Corp (UOC) is a medical device company that designs, manufactures and distributes orthopedic implants and instrument sets. The company’s product categories include knee replacement systems, hip replacement systems, and oncology products. Its hip replacement systems include …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆